CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Research methodology
1.3.1 Secondary research
1.3.2 Primary research
1.3.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO Perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market Definition & Scope
3.2 Key Findings
3.2.1 Top Investment Pockets
3.2.2 Top Winning Strategies
3.3 Porters Five Forces Analysis
3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Intensity of rivalry
3.3.5 Threat of substitutes
3.4 Market Share Analysis, 2015
3.5 Market Dynamics
3.5.1 Drivers
3.5.1.1 Increasing incidences of joint disabling diseases, trauma anD sports injuries
3.5.1.2 Technological advancements in the field of extremity implants
3.5.1.3 Increasing awareness and patient preference to maintain an active lifestyle
3.5.1.4 Obesity and diabetes epidemic increasing the risk of degenerative joint diseases
3.5.2 Restraints
3.5.2.1 High cost of surgeries
3.5.2.2 Failure, complications, and revision of surgeries and lack of trained professionals
3.5.3 Opportunities
3.5.3.1 Huge market opportunities in the Asia-pacific region and developing countries
3.5.3.2 New product introductions with innovative technologies
CHAPTER 4 WORLD EXTREMITY RECONSTRUCTION MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Upper Extremity Reconstruction
4.2.1 Key market trend
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Shoulder Replacement
4.2.4.1 Market size and forecast
4.2.4.2 Partial Shoulder Replacement
4.2.4.2.1 MARKET SIZE AND FORECAST
4.2.4.3 Total Standard Replacement
4.2.4.3.1 MARKET SIZE AND FORECAST
4.2.4.4 Stemless Total Shoulder Replacement
4.2.4.4.1 MARKET SIZE AND FORECAST
4.2.4.5 Total Reverse Replacement
4.2.4.5.1 MARKET SIZE AND FORECAST
4.2.4.6 Elbow replacement
4.2.4.6.1 MARKET SIZE AND FORECAST
4.2.4.7 Hand and wrist reconstruction
4.2.4.7.1 MARKET SIZE AND FORECAST
4.3 Lower Extremity Reconstruction
4.3.1 Key market trend
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 Foot Devices
4.3.4.1 Market size and forecast
4.3.4.2 Hindfoot Fusion Devices
4.3.4.2.1 MARKET SIZE AND FORECAST
4.3.4.3 Other fusion devices
4.3.4.3.1 MARKET SIZE AND FORECAST
4.3.5 Ankle Devices
4.3.5.1 Market size and forecast
4.3.5.2 Ankle fusion devices
4.3.5.2.1 MARKET SIZE AND FORECAST
4.3.5.3 Total Ankle replacement devices
4.3.5.3.1 MARKET SIZE AND FORECAST
CHAPTER 5 WORLD EXTREMITY RECONSTRUCTION MARKET, BY BIOMATERIAL
5.1 Overview
5.1.1 Market size and forecast
5.2 Metallic biomaterials
5.2.1 Market size and forecast
5.3 Ceramic biomaterials
5.3.1 Market size and forecast
5.4 Polymeric Biomaterials
5.4.1 Market size and forecast
5.5 Natural biomaterials
5.5.1 Market size and forecast
CHAPTER 6 WORLD EXTREMITY RECONSTRUCTION MARKET, BY GEOGRAPHY
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 U.S. Market Size and Forecast
6.2.5 Canada: Market Size and Forecast
6.2.6 Mexico: Market Size and Forecast
6.3 Europe
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 Germany: Market Size and Forecast
6.3.5 France: Market Size and Forecast
6.3.6 U.K.: Market Size and Forecast
6.3.7 Italy: Market Size and Forecast
6.3.8 Spain: Market Size and Forecast
6.3.9 Rest of Europe: Market Size and Forecast
6.4 Asia-Pacific
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 Japan: Market Size and Forecast
6.4.5 China: Market Size and Forecast
6.4.6 India: Market Size and Forecast
6.4.7 South Korea: Market Size and Forecast
6.4.8 Malaysia: Market Size and Forecast
6.4.9 Rest of Asia-Pacific: Market Size and Forecast
6.5 LAMEA
6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.5.4 Brazil: Market Size and Forecast
6.5.5 Israel: Market Size and Forecast
6.5.6 Saudi Arabia: Market Size and Forecast
6.5.7 South Africa: Market Size and Forecast
6.5.8 Rest of LAMEA: Market Size and Forecast
CHAPTER 7 COMPANY PROFILES
7.1 Acumed LLC
7.1.1 Company Overview
7.1.2 Company Snapshot
7.1.3 Operating Business Segments
7.1.4 Key Strategic Moves & Developments
7.2 Arthrex, INC.
7.2.1 Company Overview
7.2.2 Company Snapshot
7.2.3 Operating business segments
7.2.4 Key Strategic Moves & Developments
7.3 CONMED Corporation
7.3.1 Company Overview
7.3.2 Company Snapshot
7.3.3 Operating business segments
7.3.4 Business performance
7.3.5 Key Strategic Moves & Developments
7.4 Integra Lifesciences Holdings Corporation
7.4.1 Company Overview
7.4.2 Company Snapshot
7.4.3 Operating business segments
7.4.4 Business performance
7.4.5 Key Strategic Moves & Developments
7.5 Johnson & Johnson
7.5.1 Company Overview
7.5.2 Company Snapshot
7.5.3 Operating business segments
7.5.4 Business performance
7.5.5 Key Strategic Moves & Developments
7.6 Skeletal Dynamics LLC
7.6.1 Company Overview
7.6.2 Company Snapshot
7.6.3 Operating Business Segments
7.7 Smith & Nephew plc
7.7.1 Company Overview
7.7.2 Company Snapshot
7.7.3 Operating business segments
7.7.4 Business performance
7.7.5 Key Strategic Moves & Developments
7.8 Stryker Corporation
7.8.1 Company Overview
7.8.2 Company Snapshot
7.8.3 Operating business segments
7.8.4 Business performance
7.8.5 Key Strategic Moves & Developments
7.9 Wright Medical Group N.V.
7.9.1 Company Overview
7.9.2 Company Snapshot
7.9.3 Operating business segments
7.9.4 Business performance
7.9.5 Key Strategic Moves & Developments
7.10 Zimmer Biomet Holdings, Inc.
7.10.1 Company Overview
7.10.2 Company Snapshot
7.10.3 Operating business segments
7.10.4 Business performance
7.10.5 Key Strategic Moves & Developments